MASCC Prevention and Management of Acute Radiation Dermatitis Guideline Summary - Guideline Central
Summary of Recommendations
Document Overview

Prevention and Management of Acute Radiation Dermatitis

Multinational Association of Supportive Care in Cancer


Publication Date: Mar 27, 2023

Page Last Updated: May 5, 2026



Document Overview

Document Title
Prevention and Management of Acute Radiation Dermatitis
Authoring Society

Multinational Association of Supportive Care in Cancer

Document Publication Date
Mar 27, 2023
Page Last Reviewed/Updated
May 5, 2026
Document Type
Guideline
Country of Publication
Global
Full Text Freely Available
Yes
Full Text Guideline
mascc.org/wp-content/uploads/2023/03/Guideline_ARD_part_2_2023-03-27.pdf

Supplemental Implementation Resources


Document Scope, Criteria, and Use Cases

Document Objectives
Acute radiation dermatitis is a frequent adverse effect of radiotherapy, but standardisation of care for acute radiation dermatitis is lacking. Due to the conflicting evidence and variability in current guidelines, a four-round Delphi consensus process was used to compile opinions of 42 international experts on care for people with acute radiation dermatitis on the basis of the evidence in existing medical literature. Interventions for acute radiation dermatitis prevention or management that reached at least 75% consensus were recommended for clinical use. Six interventions could be recommended for the prevention of acute radiation dermatitis: photobiomodulation therapy and Mepitel film in people with breast cancer, Hydrofilm, mometasone, betamethasone, and olive oil. Mepilex Lite dressings were recommended for the management of acute radiation dermatitis. Most interventions were not recommended due to insufficient evidence, conflicting evidence, or lack of consensus to support use, suggesting a need for further research. Clinicians can consider implementing recommended interventions in their practice to prevent and manage acute radiation dermatitis until additional evidence becomes available.
Scope
Management, Prevention
Diseases/Conditions (MeSH)

D003872 - Dermatitis

D011827 - Radiation

D017453 - Dermatitis, Irritant

D017484 - Dermatitis, Phototoxic

D011830 - Radiation Effects

D003872 - Dermatitis

D011827 - Radiation

D017453 - Dermatitis, Irritant

D017484 - Dermatitis, Phototoxic

D011830 - Radiation Effects

Keywords
Fractionated radiotherapy, Radiation Dermatitis, cancer, dermatitis, radiotherapy
Inclusion Criteria
Male, Female, Adult, Older Adult
Health Care Settings
Ambulatory, Outpatient, Radiology Services
Intended Users
Nurse, Nurse Practitioner, Physician, Physician Assistant

Recommendation Development Processes & Methodology

Supplemental Methodology Resource
Systematic Review Document
Number of Source Documents
32
Includes peer/external review process?
Yes
Includes public comment process?
No
Methodologist involvement?
Yes
Patient involvement?
No
Includes multi-disciplinary group?
Yes
Includes systematic review?
Yes
Grades quality of strength of evidence?
No
Grades quality of strength of recommendation?
No
Discloses funding source?
Yes
Discloses conflicts of interest?
Yes
Includes benefits/harms analysis with recommendations?
No
You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.